Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT

Citrate has been proposed as anticoagulation of choice in continuous renal replacement therapy (CRRT). However, little is known about the pharmacokinetics (PK) and metabolism of citrate in liver failure patients who require CRRT with regional citrate anticoagulation (RCA). This prospective clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanapongsatorn, Peerapat, Chaijamorn, Weerachai, Sirivongrangson, Phatadon, Tachaboon, Sasipha, Peerapornratana, Sadudee, Lumlertgul, Nuttha, Lucksiri, Aroonrut, Srisawat, Nattachai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810887/
https://www.ncbi.nlm.nih.gov/pubmed/35110648
http://dx.doi.org/10.1038/s41598-022-05867-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810887/
https://www.ncbi.nlm.nih.gov/pubmed/35110648
http://dx.doi.org/10.1038/s41598-022-05867-8

Ejemplares similares